NCT04068623Active, not recruiting
Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients
PERCEPTION Trial Protocol: Comparison of Predictive and Prognostic Capacities of Neutrophil, Lymphocyte and Platelet Counts and Tumour-infiltrating Lymphocytes in Triple Negative Breast Cancer
Source: ClinicalTrials.gov · Last updated 20 Mar 2026
Brief summary (registry, in English)
The PERCEPTION study aims to assess the correlation between blood cell counts (Leucocytes, Neutrophils, Lymphocytes, Platelets, NLR (Neutrophil-to-Lymphocyte Ratio) and PLR (Platelet-to-Lymphocyte Ratio)) and Tumor Infiltrating Lymphocytes (TILs), at baseline and after surgery, for patients diagnosed with triple negative breast cancer. It also aims to assess these circulating elements and circulating tumor DNA as predictive factor of metastatic recurrence in triple negative breast cancer.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 90 (estimated)
- First submitted
- 31 Jul 2019
- Start date
- 4 Dec 2019
- Primary completion date
- 31 Oct 2027
- Lead sponsor
- Centre Jean Perrin
- Diseases
- Triple-negative breast cancer
- NCT number
- NCT04068623
What you commit to
- Study type: Observational
- Planned participants: 90
- From 4 Dec 2019 to the primary completion date, 31 Oct 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Male
- Unavailable tumoral samples before inclusion
- Unavailable blood test results at baseline, before inclusion
Who the study is looking for
- Female
- Age \> 18 years
- Diagnosed with primitive, non-metastatic, histologically proved, triple negative breast cancer
- Patient treated with chemotherapy, surgery and radiation therapy
- Patient able to understand the French language
- Patient affiliated to social security
- Obtaining signed written consent
Age in the registry: 18 years to - · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Jean Perrin Coordinator of this site? Confirm its status | Clermont-Ferrand | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.